TREA

Using a guided member to facilitate brachytherapy device swap

Follow

Information

  • Patent Grant
  • 10022557
  • Patent Number
    10,022,557
  • Date Filed
    Friday, May 27, 2016
    8 years ago
  • Date Issued
    Tuesday, July 17, 2018
    6 years ago
Information
Abstract
A guide member facilitates a device swap for brachytherapy treatment. A cavity evaluation device is introduced during surgery such that a distal end of the device is disposed in a resected cavity of the patient. The cavity evaluation device includes a shaft in which is disposed an elongated guide member. In a subsequent out-patient procedure the cavity evaluation device is removed from the resected cavity. If a brachytherapy treatment is to be performed then the cavity evaluation device is removed without removing the elongated guide member such that position of a portion of the elongated guide member in the resected cavity is maintained relative to the resected cavity. An anchor member helps to maintain the position of the guide member. Introduction of a brachytherapy catheter is then facilitated by introducing the elongated guide member into an opening of the brachytherapy catheter and using the elongated guide member to guide the brachytherapy catheter to the resected cavity.
Description
BACKGROUND OF THE INVENTION

The present invention is generally related to medical treatments, and more particularly to interstitial Brachytherapy. Malignant tumors are often treated by surgical resection to remove as much of the tumor as possible. Radiation therapy can then be used to target the residual tumor margin. The radiation therapy can be administered through various methods including external-beam radiation, stereotactic radiosurgery, and permanent or temporary brachytherapy.


Brachytherapy is a radiation therapy in which a source of therapeutic rays is inserted into the body at or near a tumor or other proliferative tissue disease site. At least one breast brachytherapy radiation treatment begins with insertion of a cavity evaluation device into the resected cavity during the lumpectomy procedure. If it is later determined that the patient is to be given brachytherapy treatment then the cavity evaluation device is removed during an office visit and a brachytherapy catheter is inserted into the path through the tissue previously occupied by the cavity evaluation device. More particularly, the catheter shaft is inserted into the tissue so that a balloon disposed at the distal end of the shaft is positioned within the resected cavity. The balloon is then inflated and radioactive material is loaded into one or more lumens for delivery via the brachytherapy catheter. The brachytherapy catheter is removed upon completion of the treatment.


SUMMARY OF THE INVENTION

The present invention is predicated in-part on recognition that introducing a device such as a brachytherapy catheter into a path previously occupied by a device such as a cavity evaluation device can be difficult to perform as an out-patient procedure. Because the path is through soft tissue it can close rapidly and does not always accurately guide the brachytherapy catheter to the resected cavity.


In accordance with an aspect of the invention, a method for facilitating brachytherapy treatment comprises the steps of: positioning a first device such that a distal end of the first device is disposed in a resected cavity of the patient, the first device including a shaft in which is disposed an elongated guide member; removing the first device from the resected cavity without removing the elongated guide member such that position of a portion of the elongated guide member in the resected cavity is maintained relative to the resected cavity; and introducing a brachytherapy catheter by introducing the elongated guide member into an opening of the brachytherapy catheter and using the elongated guide member to guide the brachytherapy catheter to the resected cavity.


In accordance with another aspect of the invention, apparatus for facilitating brachytherapy treatment comprises: a shaft; a tip disposed at a first end of the shaft; an inflatable member disposed around the shaft; an inflation lumen which transfers fluid into and out of the inflatable member; and an opening in the tip which receives a separate elongated guide member, and via which the guide member can be introduced to soft tissue.


In accordance with another aspect of the invention, apparatus for facilitating brachytherapy treatment comprises: a shaft; a tip disposed at a first end of the shaft; an inflatable member disposed around the shaft; an inflation lumen which transfers fluid into and out of the inflatable member; at least one dosing lumen; and an opening in the tip which receives a separate elongated guide member, and through which the guide member slidably moves in order to guide the apparatus through soft tissue.


One advantage of the guide member is that it helps to guide the brachytherapy catheter to the resected cavity. Furthermore, the guide member helps to accurately position the brachytherapy catheter and associated dosing lumens within the resected cavity.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 illustrates a cavity evaluation device adapted to introduce a guide member.



FIG. 2 illustrates an embodiment of a guide member.



FIGS. 3 and 4 illustrate an alternative embodiment of the cavity evaluation device and guide member.



FIG. 5 illustrates withdrawal of the cavity evaluation device while guide member position is maintained.



FIG. 6 illustrates use of a brachytherapy catheter adapted to utilize the guide member.



FIG. 7 illustrates an alternative embodiment of the cavity evaluation device or brachytherapy catheter.



FIGS. 8 and 9 illustrate apparatus for facilitating introduction of the guide member and prevention of contamination.





DETAILED DESCRIPTION


FIG. 1 illustrates a medical device 100 adapted to introduce a guide member 102 into soft tissue to facilitate swapping of medical devices associated with a treatment such as interstitial brachytherapy, e.g., swapping a cavity evaluation device for a brachytherapy catheter. Device 100 may be a type of cavity evaluation device which includes a shaft 104, hub 110, inflatable member 106, inflation lumen 108, and a tubular opening or lumen 112 for a separate guide member 102. The shaft is characterized by a proximal end (hub) and a distal end (tip 110). The inflation lumen is coupled at the proximal end to a connector (not illustrated). Once the device is positioned within the resected cavity the inflatable member is inflated, which helps maintain the device in position.


Referring to FIGS. 1 and 2, an opening in the tip 110 at the distal end of the shaft enables the elongated guide member 102 to be slidably moved into and out of the shaft 104. More particularly, the guide member 102 slides into or out of the tubular opening 112 formed in the shaft or a lumen disposed in the shaft. The guide member 102 includes a guide wire 200 and may also include an anchor member 202 at its distal end. The anchor member 202 helps to maintain the guide member 102 in a fixed position relative to surrounding tissue following introduction. This is accomplished by increasing resistance against the surrounding tissue to inhibit movement. The guide wire 200 and anchor member 202 may be made from a flexible material including but not limited to metallics such as nickel titanium (Nitinol), polyurethane, nylon, Polyether Block Amide (PEBA), Low-density polyethylene (LDPE), thermoplastic polyester elastomers, or PolyEtherEther-Ketone (PEEK). In one embodiment the guide wire and anchor member are imagable via various modalities based on sonic, electromagnetic or magnetic resonance imaging techniques. In the illustrated embodiment the anchor member 202 is disk-shaped and the guide wire 200 is attached at the center of the anchor member approximately perpendicular to a plane defined by the anchor member. However, those skilled in the art will recognize that the anchor member could have any of various alternative shapes and types of connection to the guide wire. For example, and without limitation, an anchor member 400 (FIGS. 3 and 4) may be characterized by a curvature that matches the portion of the tip 110 against which the anchor member will be disposed when loaded into device 100.


Referring now to FIGS. 1 through 6, the device 100 is pre-loaded with a guide member 102 before being introduced during the lumpectomy procedure. More particularly, the guide member 102 is introduced such that the distal end and inflatable member 106 are positioned within the resected cavity. Imaging equipment may be utilized to facilitate proper positioning. The inflatable member is then inflated by coupling the device to a source of pressurized fluid via connector. The inflation fluid flows into the inflatable member via the inflation lumen 108. One or more inflation holes (not shown) extend through the inflation lumen into the inflatable member. Once inflated, the inflatable member 106 helps to maintain the position of the device 100 with respect to the resected cavity. The connector is then detached from the fluid source and the device is left in place.


If it is later determined that the patient is to be given brachytherapy treatment then the device 100 is removed during an office visit and a brachytherapy catheter 600 with an inflatable member 602, such as a balloon, mounted on its distal end is inserted into the track through the tissue previously occupied by the cavity evaluation device 100. More particularly, the inflatable member 106 is deflated and the cavity evaluation device 100 is removed while the position of the guide member 102 relative to the resected cavity is maintained. Deployment of the guide member by creating separation between the anchor member 202 and the tip 110 (see FIG. 4) can help maintain the position of the guide member 102 during removal of the cavity evaluation device by, for example, preventing the anchor member from inadvertently latching onto or adhering to the tip. The guide member 102 may be deployed either before or after deflation of the inflatable member 106 by pushing on a free end of the guide wire. In either case, the inflatable member is deflated in order to permit removal of the cavity evaluation device. A portion of the guide wire 200 may extend out from the body of the patient following complete removal of the cavity evaluation device 100 in order to facilitate insertion of the guide wire into a receiver of the brachytherapy catheter shaft. It will be appreciated that the cavity evaluation device can alternatively be removed without deploying the guide member, i.e., removed along with the guide member, if necessary or desirable.


Referring now to FIG. 6, a flexible brachytherapy catheter 600 includes a flexible shaft 601, an inflatable member 602, at least one flexible dosing lumen 604, an inflation lumen (not illustrated), a guide lumen or tubular opening (collectively 606), a tip 608 and rigid section 609. Each dosing lumen 604 is sized to accommodate one or more radiation sources. The inflation lumen is coupled at a proximal end to a connector for introducing fluid for inflation. The lumens are made, for example, from a flexible material such as polyurethane, Nylon, Pebax, LDPE, Hytrel, or PEEK. Each dosing lumen 604 slidably extends through the flexible shaft and into openings which extend longitudinally into the rigid section 609. The openings in the rigid section are sized so that the exterior of each dosing lumen is tightly received in its respective opening. The lumens may be fixedly attached to the rigid section using an adhesive. The inflatable member functions in the same manner as the inflatable member of the device 100.


With the guide member 102 deployed (i.e. separated from the cavity evaluation device 100) and the device 100 removed from the patient, the guide wire 200 is used to facilitate introduction of the brachytherapy catheter device 600 by guiding the catheter through the existing opening in the soft tissue. As indicated above, the catheter shaft 601 includes a tip 608 with at least one opening 606 sized to receive the guide wire. Once inserted into the opening in the tip, the guide wire 200 is received by the associated lumen or tubular opening 606 as the brachytherapy catheter 600 is inserted into the soft tissue. Those skilled in the art will recognize that the flexibility of the guide wire 200 and resistance presented by the anchor member 202 in the soft tissue may be adjusted to achieve a desired result for a particular type of soft tissue, e.g., to present suitable resistance against movement. For example, the anchor member could be inflatable. The brachytherapy catheter 600 is eventually moved slidably along the guide wire to the extent that the tip 608 of the brachytherapy catheter contacts the anchor member 202, thereby indicating completion of that part of the procedure and helping to assure proper positioning of the brachytherapy catheter and associated dosing lumens with respect to the resected cavity 610. The inflatable member 602 is inflated after the tip of the catheter contacts the anchor member. The dosing lumens 604 are then used to deliver radiation therapy as already known in the art. The guide member 102 may be removed along with the brachytherapy catheter 600 once the treatment is completed. Alternatively, the guide member may be left in place if desired.



FIG. 7 illustrates an alternative embodiment of the cavity evaluation device or brachytherapy catheter (collectively 700). In this alternative embodiment the device 700 includes a non-linear lumen or tubular opening 702 for receiving the guide wire. More particularly, the lumen or tubular opening is characterized by an arcuate turn through approximately 90 degrees such that the anchor member 202 is disposed against a side of the tip 704. One advantage of this embodiment is that the anchor member does not cover the portion of the tip where channels for lumens may be placed.



FIGS. 8 and 9 illustrate apparatus for facilitating introduction of the guide member and prevention of contamination. As described above, proper positioning of the anchor member 202 facilitates proper positioning of the brachytherapy catheter 600 and dosing lumens 604. Because soft tissue may present relatively little resistance to removal of the guide member 102 during withdrawal of the cavity evaluation device 100, a separate tool 800 may be used to apply force against the free end of the guide wire 200 as the cavity evaluation device is withdrawn. The tool 800 may include an outer sheath 802 in which a push wire 804 is disposed. The free end of the guide wire is threaded into the sheath and pressure is applied against the guide wire by means of the push wire as the cavity evaluation device is withdrawn. Note that this helps to prevent both movement of the anchor member and contamination of the free end of the guide wire. Moreover, the sheath may be capped and remain in place following removal of the cavity evaluation device and push wire in order to help prevent contamination if the cavity evaluation tool will not be immediately replaced with the brachytherapy catheter.


While the invention is described through the above exemplary embodiments, it will be understood by those of ordinary skill in the art that modification to and variation of the illustrated embodiments may be made without departing from the inventive concepts herein disclosed. Moreover, while the preferred embodiments are described in connection with various illustrative structures, one skilled in the art will recognize that the system may be embodied using a variety of specific structures. Accordingly, the invention should not be viewed as limited except by the scope and spirit of the appended claims.

Claims
  • 1. An apparatus for facilitating brachytherapy treatment comprising: an elongated guide member comprising a guide wire and a non-inflatable anchor member at a distal end of the guide wire, wherein the non-inflatable anchor member comprises a curvature; anda device comprising: a shaft defining a lumen configured to slidably receive the elongated guide member;a tip disposed at a first end of the shaft, wherein the tip comprises an outer curvature configured to mate with the non-inflatable anchor curvature when the elongated guide member is received in the lumen;an inflatable member disposed around the shaft;an inflation lumen which transfers fluid into and out of the inflatable member; andan opening in the tip which receives the elongated guide member, and via which the elongated guide member can be introduced to soft tissue, wherein the opening is sized so as to receive all but the non-inflatable anchor member of the elongated guide member.
  • 2. The apparatus of claim 1 further including a dosing lumen disposed in the shaft to receive a radiation source.
  • 3. The apparatus of claim 1 wherein the non-inflatable anchor member curvature is contoured to match the tip outer curvature against which the non-inflatable anchor member is disposed when the guide wire is loaded into the shaft.
  • 4. The apparatus of claim 3 wherein the opening in the tip is through a side of the tip.
  • 5. The apparatus of claim 3 wherein the opening in the tip is through a most distal portion of the tip.
  • 6. The apparatus of claim 3 further including a sheath disposed around a free end of the guide wire.
  • 7. The apparatus of claim 6 further including a push wire inserted into the sheath to apply force against the free end of the guide wire.
  • 8. The apparatus of claim 1, wherein the shaft comprises a rigid portion and a flexible portion and wherein the inflatable member is disposed about the rigid portion.
  • 9. The apparatus of claim 1, wherein the device is a brachytherapy catheter.
  • 10. The apparatus of claim 1, wherein the device is a cavity evaluation device.
  • 11. The apparatus of claim 1, wherein the opening is defined by the tip of the shaft.
  • 12. The apparatus of claim 1, wherein the opening is defined by a side surface of the shaft.
  • 13. The apparatus of claim 1, wherein the lumen is defined by a portion of the shaft that is off-center of the shaft.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of and claims the benefit of priority of U.S. application Ser. No. 12/894,888, filed Sep. 30, 2010, now U.S. Pat. No. 9,352,172, entitled “Using a Guide Member to Facilitate Brachytherapy Device Swap”, the disclosure of which is hereby incorporated by reference herein.

US Referenced Citations (436)
Number Name Date Kind
3324847 Zoumboulis Jun 1967 A
3502878 Stewart Mar 1970 A
3863073 Wagner Jan 1975 A
3872856 Clayton Mar 1975 A
3971950 Evans et al. Jul 1976 A
3975350 Hudgin et al. Aug 1976 A
4119094 Micklus et al. Oct 1978 A
4160906 Daniels et al. Jul 1979 A
4310766 Finkenzeller et al. Jan 1982 A
4350169 Dutcher et al. Sep 1982 A
4417576 Baran Nov 1983 A
4454106 Gansow et al. Jun 1984 A
4496557 Malen et al. Jan 1985 A
4559641 Caugant et al. Dec 1985 A
4571241 Christopher Feb 1986 A
4690677 Erb Sep 1987 A
4706269 Reina et al. Nov 1987 A
4706652 Horowitz Nov 1987 A
4744099 Huettenrauch et al. May 1988 A
4754745 Horowitz Jul 1988 A
4763642 Horowitz Aug 1988 A
4773086 Fujita et al. Sep 1988 A
4773087 Plewes Sep 1988 A
4819258 Kleinman et al. Apr 1989 A
4821725 Azam et al. Apr 1989 A
4821727 Levene et al. Apr 1989 A
4867741 Portnoy Sep 1989 A
4929470 Rittenhouse et al. May 1990 A
4969174 Scheid et al. Nov 1990 A
4989227 Tirelli et al. Jan 1991 A
4998917 Geiser et al. Mar 1991 A
4998930 Lundahl Mar 1991 A
5015247 Michaelson May 1991 A
5018176 Romeas et al. May 1991 A
RE33634 Yanaki Jul 1991 E
5029193 Saffer Jul 1991 A
5051904 Griffith Sep 1991 A
5059166 Fischell et al. Oct 1991 A
5078142 Siczek et al. Jan 1992 A
5084001 Vant Hooft et al. Jan 1992 A
5084015 Moriuchi Jan 1992 A
5084022 Claude Jan 1992 A
5106360 Ishiwara et al. Apr 1992 A
5112303 Pudenz et al. May 1992 A
5152747 Olivier Oct 1992 A
5163075 Lubinsky et al. Nov 1992 A
5164976 Scheid et al. Nov 1992 A
5167622 Muto Dec 1992 A
5199056 Darrah Mar 1993 A
5199939 Dake et al. Apr 1993 A
5227969 Waggener et al. Jul 1993 A
5236410 Granov et al. Aug 1993 A
5240011 Assa Aug 1993 A
5259847 Trambert Nov 1993 A
5289520 Pellegrino et al. Feb 1994 A
5302168 Hess Apr 1994 A
5312356 Engelson et al. May 1994 A
5314518 Ito et al. May 1994 A
5336178 Kaplan et al. Aug 1994 A
5342305 Shonk Aug 1994 A
5359637 Webber Oct 1994 A
5365562 Toker Nov 1994 A
5381504 Novack et al. Jan 1995 A
5411466 Hess May 1995 A
5415169 Siczek et al. May 1995 A
5417687 Nardella et al. May 1995 A
5422926 Smith et al. Jun 1995 A
5426685 Pellegrino et al. Jun 1995 A
5428658 Oettingger et al. Jun 1995 A
5429582 Williams Jul 1995 A
5452367 Bick et al. Sep 1995 A
5465733 Hinohara Nov 1995 A
5484384 Fearnot Jan 1996 A
5503613 Weinberger Apr 1996 A
5506877 Niklason et al. Apr 1996 A
5520646 D'Andrea May 1996 A
5526394 Siczek et al. Jun 1996 A
5535817 Dunne Jul 1996 A
5539797 Heidsieck et al. Jul 1996 A
5553111 Moore et al. Sep 1996 A
5562594 Weeks Oct 1996 A
5566221 Smith et al. Oct 1996 A
5592562 Rooks Jan 1997 A
5594769 Pellegrino et al. Jan 1997 A
5596200 Sharma et al. Jan 1997 A
5598454 Franetzki et al. Jan 1997 A
5603991 Kupiecki et al. Feb 1997 A
5609152 Pellegrino et al. Mar 1997 A
5611767 Williams Mar 1997 A
5616114 Thornton et al. Apr 1997 A
5621780 Smith et al. Apr 1997 A
5624395 Mikhail et al. Apr 1997 A
5627869 Andrew et al. May 1997 A
5653683 D'Andrea Aug 1997 A
5657362 Giger et al. Aug 1997 A
5662580 Bradshaw et al. Sep 1997 A
5668889 Hara Sep 1997 A
5704926 Sutton Jan 1998 A
5706327 Adamkowski et al. Jan 1998 A
5719952 Rooks Feb 1998 A
5720717 D'Andrea Feb 1998 A
5724400 Swerdloff et al. Mar 1998 A
5735264 Siczek et al. Apr 1998 A
5741253 Michaelson Apr 1998 A
5759173 Preissman et al. Jun 1998 A
5769086 Ritchart et al. Jun 1998 A
5782742 Crocker et al. Jul 1998 A
5800333 Liprie Sep 1998 A
5803895 Kronholz et al. Sep 1998 A
5803912 Siczek et al. Sep 1998 A
5818898 Tsukamoto et al. Oct 1998 A
5820594 Fontirroche et al. Oct 1998 A
5820717 Siegenthaler Oct 1998 A
5828722 Ploetz et al. Oct 1998 A
5851182 Sahadevan Dec 1998 A
5863284 Klein Jan 1999 A
5863285 Coletti Jan 1999 A
5872828 Niklason et al. Feb 1999 A
5878104 Ploetz Mar 1999 A
5896437 Ploetz Apr 1999 A
5899882 Waksman et al. May 1999 A
5908406 Ostapchenko et al. Jun 1999 A
5913813 Williams et al. Jun 1999 A
5916143 Apple et al. Jun 1999 A
5919473 Elkhoury Jul 1999 A
5924973 Weinberger Jul 1999 A
5931774 Willaims et al. Aug 1999 A
5935098 Blaisdell et al. Aug 1999 A
5986662 Argiro et al. Nov 1999 A
5993972 Reich et al. Nov 1999 A
6005907 Ploetz Dec 1999 A
6013038 Pflueger Jan 2000 A
6022308 Williams Feb 2000 A
6022325 Siczek et al. Feb 2000 A
6033357 Ciezki et al. Mar 2000 A
6036631 McGrath et al. Mar 2000 A
6050930 Teirstein Apr 2000 A
6056702 Lorenzo May 2000 A
6075879 Roehrig et al. Jun 2000 A
6083148 Williams Jul 2000 A
6086970 Ren Jul 2000 A
6091841 Rogers et al. Jul 2000 A
6093142 Ciamacco, Jr. Jul 2000 A
6095966 Chomenky et al. Aug 2000 A
6137527 Abdel-Malek et al. Oct 2000 A
6141398 He et al. Oct 2000 A
6143013 Samson et al. Nov 2000 A
6149301 Kautzer et al. Nov 2000 A
6175117 Komardin et al. Jan 2001 B1
6196715 Nambu et al. Mar 2001 B1
6200257 Winkler Mar 2001 B1
6216540 Nelson et al. Apr 2001 B1
6217565 Cohen Apr 2001 B1
6219059 Argiro Apr 2001 B1
6233473 Shepherd et al. May 2001 B1
6234952 Liprie May 2001 B1
6243441 Zur Jun 2001 B1
6248122 Klumb et al. Jun 2001 B1
6251059 Apple et al. Jun 2001 B1
6256370 Yavuz Jul 2001 B1
6256529 Holupka et al. Jul 2001 B1
6267775 Clerc et al. Jul 2001 B1
6272207 Tang Aug 2001 B1
6282142 Miyawaki Aug 2001 B1
6289235 Webber et al. Sep 2001 B1
6292530 Yavus et al. Sep 2001 B1
6306074 Waksman et al. Oct 2001 B1
6319188 Lovoi Nov 2001 B1
6327336 Gingold et al. Dec 2001 B1
6341156 Baetz et al. Jan 2002 B1
6375352 Hewes et al. Apr 2002 B1
6378137 Hassan et al. Apr 2002 B1
6390967 Forman et al. May 2002 B1
6390968 Harmon May 2002 B1
6390992 Morris et al. May 2002 B1
6398708 Hastings et al. Jun 2002 B1
6411836 Patel et al. Jun 2002 B1
6413203 Sahatjian Jul 2002 B1
6413204 Winkler et al. Jul 2002 B1
6415015 Nicolas et al. Jul 2002 B2
6416457 Urick et al. Jul 2002 B1
6416492 Nielson Jul 2002 B1
6442288 Haerer et al. Aug 2002 B1
6443912 Mazzola et al. Sep 2002 B1
6458069 Tam et al. Oct 2002 B1
6458070 Waksman et al. Oct 2002 B1
6459925 Nields et al. Oct 2002 B1
6482124 Winkler et al. Nov 2002 B2
6482142 Winkler et al. Nov 2002 B1
6501819 Unger et al. Dec 2002 B2
6512942 Burdette et al. Jan 2003 B1
6527693 Munro, III et al. Mar 2003 B2
6540655 Chin et al. Apr 2003 B1
6556655 Chichereau et al. Apr 2003 B1
6558390 Cragg May 2003 B2
6579221 Peterson Jun 2003 B1
6597762 Ferrant et al. Jul 2003 B1
6605030 Weinberger Aug 2003 B2
6607477 Longton et al. Aug 2003 B1
6610013 Fenster et al. Aug 2003 B1
6611575 Alyassin et al. Aug 2003 B1
6615070 Lee Sep 2003 B2
6616629 Verin et al. Sep 2003 B1
6620111 Stephens et al. Sep 2003 B2
6626849 Huitema et al. Sep 2003 B2
6633674 Gemperline et al. Oct 2003 B1
6638235 Miller et al. Oct 2003 B2
6647092 Eberhard et al. Nov 2003 B2
6652441 Weinberger et al. Nov 2003 B2
6673006 Winkler Jan 2004 B2
6685618 Tam et al. Feb 2004 B2
6706014 Banik et al. Mar 2004 B2
6723052 Mills Apr 2004 B2
6744848 Stanton et al. Jun 2004 B2
6746392 Stiger et al. Jun 2004 B2
6748044 Sabol et al. Jun 2004 B2
6749555 Winkler et al. Jun 2004 B1
6749595 Murphy Jun 2004 B1
6751285 Eberhard et al. Jun 2004 B2
6752752 Geitz Jun 2004 B2
6758824 Miller et al. Jul 2004 B1
6770058 Liprie Aug 2004 B1
6813334 Koppe et al. Nov 2004 B2
6882700 Wang et al. Apr 2005 B2
6885724 Li et al. Apr 2005 B2
6912319 Barnes et al. Jun 2005 B1
6913600 Valley et al. Jul 2005 B2
6923754 Lubock Aug 2005 B2
6940943 Claus et al. Sep 2005 B2
6955641 Lubock Oct 2005 B2
6970531 Eberhard et al. Nov 2005 B2
6978040 Berestov Dec 2005 B2
6983754 Anderson et al. Jan 2006 B1
6987831 Ning Jan 2006 B2
6999554 Mertelmeier Feb 2006 B2
7098463 Adamovics Aug 2006 B2
7107089 Lee Sep 2006 B2
7110490 Eberhard et al. Sep 2006 B2
7110502 Tsuji Sep 2006 B2
7123684 Jing et al. Oct 2006 B2
7127091 Op De Beek et al. Oct 2006 B2
7142633 Eberhard et al. Nov 2006 B2
7171255 Holupka et al. Jan 2007 B2
7201715 Burdette et al. Apr 2007 B2
7214178 Lubock May 2007 B2
7245694 Jing et al. Jul 2007 B2
7315607 Ramsauer Jan 2008 B2
7319735 Defreitas Jan 2008 B2
7322929 Lovoi Jan 2008 B2
7323692 Rowlands et al. Jan 2008 B2
7404791 Linares et al. Jul 2008 B2
7407476 Lubock et al. Aug 2008 B2
7413539 Lubock et al. Aug 2008 B2
7430272 Jing et al. Sep 2008 B2
7443949 Defreitas et al. Oct 2008 B2
7465268 Lubock et al. Dec 2008 B2
7476235 Diederich et al. Jan 2009 B2
7497819 White et al. Mar 2009 B2
7497820 White et al. Mar 2009 B2
7513861 Klein et al. Apr 2009 B2
7517310 Lubock et al. Apr 2009 B2
7609806 Defreitas et al. Oct 2009 B2
7630533 Ruth et al. Dec 2009 B2
7662082 White et al. Feb 2010 B2
7697660 Ning Apr 2010 B2
7783006 Stewart et al. Aug 2010 B2
7792245 Hitzke et al. Sep 2010 B2
7869563 Defreitas et al. Jan 2011 B2
7885382 Stewart et al. Feb 2011 B2
7887476 Hermann et al. Feb 2011 B2
7955246 Lubock et al. Jun 2011 B2
8075469 Lubock et al. Dec 2011 B2
8079946 Lubock et al. Dec 2011 B2
8123722 Chang et al. Feb 2012 B2
8137256 Cutrer et al. Mar 2012 B2
8192344 Lubock et al. Jun 2012 B2
8277370 Quick Oct 2012 B2
8287442 Quick Oct 2012 B2
8565374 Defreitas et al. Oct 2013 B2
9180312 Lubock et al. Nov 2015 B2
9248311 Damarati Feb 2016 B2
9352172 Benson May 2016 B2
9415239 Lubock Aug 2016 B2
9579524 Damarati Feb 2017 B2
20010016725 Valley et al. Aug 2001 A1
20010038681 Stanton et al. Nov 2001 A1
20010038861 Hsu et al. Nov 2001 A1
20010049464 Ganz Dec 2001 A1
20010051669 McGhee Dec 2001 A1
20020012450 Tsujii Jan 2002 A1
20020026090 Kaplan et al. Feb 2002 A1
20020045893 Lane et al. Apr 2002 A1
20020050986 Inoue et al. May 2002 A1
20020055666 Hunter et al. May 2002 A1
20020075997 Unger et al. Jun 2002 A1
20020095114 Palasis Jul 2002 A1
20020156342 Burton et al. Oct 2002 A1
20020177804 Saab Nov 2002 A1
20020177870 Sepetka Nov 2002 A1
20030018272 Treado et al. Jan 2003 A1
20030073895 Nields et al. Apr 2003 A1
20030095624 Eberhard May 2003 A1
20030144570 Hunter et al. Jul 2003 A1
20030153803 Harmon Aug 2003 A1
20030191491 Duane et al. Oct 2003 A1
20030194050 Eberhard Oct 2003 A1
20030194051 Wang et al. Oct 2003 A1
20030194121 Eberhard et al. Oct 2003 A1
20030210254 Doan et al. Nov 2003 A1
20030215120 Uppaluri et al. Nov 2003 A1
20040015193 Lamson Jan 2004 A1
20040039437 Sparer et al. Feb 2004 A1
20040054366 Davison et al. Mar 2004 A1
20040066884 Hermann Claus et al. Apr 2004 A1
20040066904 Eberhard et al. Apr 2004 A1
20040087827 Lubock May 2004 A1
20040094167 Brady et al. May 2004 A1
20040101095 Jing et al. May 2004 A1
20040109529 Eberhard et al. Jun 2004 A1
20040116767 Lebovic et al. Jun 2004 A1
20040147800 Barber et al. Jul 2004 A1
20040171986 Tremaglio, Jr. et al. Sep 2004 A1
20040215048 Lubock Oct 2004 A1
20040260142 Lovoi Dec 2004 A1
20040267157 Miller et al. Dec 2004 A1
20050016771 Mayes et al. Jan 2005 A1
20050049521 Miller et al. Mar 2005 A1
20050059990 Ayala et al. Mar 2005 A1
20050061771 Murphy Mar 2005 A1
20050063509 DeFreitas et al. Mar 2005 A1
20050078797 Danielsson et al. Apr 2005 A1
20050080313 Stewart et al. Apr 2005 A1
20050101823 Linares et al. May 2005 A1
20050105679 Wu et al. May 2005 A1
20050113681 DeFreitas May 2005 A1
20050113715 Schwindt et al. May 2005 A1
20050124843 Singh Jun 2005 A1
20050129172 Mertelmeier Jun 2005 A1
20050135555 Claus et al. Jun 2005 A1
20050135664 Kaufhold et al. Jun 2005 A1
20050182286 Lubock Aug 2005 A1
20050226375 Eberhard et al. Oct 2005 A1
20050240073 Apffelstaedt et al. Oct 2005 A1
20050240074 Lubock Oct 2005 A1
20050267320 Barber et al. Dec 2005 A1
20050277577 Hunter et al. Dec 2005 A1
20060014997 Kindlein et al. Jan 2006 A1
20060020156 Shukla Jan 2006 A1
20060020256 Bell et al. Jan 2006 A1
20060030784 Miller et al. Feb 2006 A1
20060074288 Kelly Apr 2006 A1
20060098855 Gkanatsios May 2006 A1
20060100475 White et al. May 2006 A1
20060116546 Eng Jun 2006 A1
20060129062 Nicoson et al. Jun 2006 A1
20060136051 Furst et al. Jun 2006 A1
20060149186 Wantink Jul 2006 A1
20060155209 Miller et al. Jul 2006 A1
20060167416 Mathis et al. Jul 2006 A1
20060173233 Lovoi Aug 2006 A1
20060173235 Lim et al. Aug 2006 A1
20060205992 Lubock et al. Sep 2006 A1
20060291618 Eberhard et al. Dec 2006 A1
20070005003 Patterson et al. Jan 2007 A1
20070030949 Jing et al. Feb 2007 A1
20070036265 Jing et al. Feb 2007 A1
20070055144 Neustadter et al. Mar 2007 A1
20070076844 Defreitas et al. Apr 2007 A1
20070106108 Hermann et al. May 2007 A1
20070142694 Cutrer et al. Jun 2007 A1
20070142779 Duane Jun 2007 A1
20070167665 Hermann et al. Jul 2007 A1
20070167666 Lubock et al. Jul 2007 A1
20070191667 Lubock et al. Aug 2007 A1
20070223651 Wagenaar et al. Sep 2007 A1
20070225600 Weibrecht Sep 2007 A1
20070242800 Jing Oct 2007 A1
20070270627 Cutrer et al. Nov 2007 A1
20080009659 Smith et al. Jan 2008 A1
20080019581 Gkanatsios Jan 2008 A1
20080045833 Defreitas Feb 2008 A1
20080057298 Finley Mar 2008 A1
20080064915 Lubock Mar 2008 A1
20080071212 Lubock et al. Mar 2008 A1
20080086083 Towler Apr 2008 A1
20080091055 Nguyen et al. Apr 2008 A1
20080101537 Sendai May 2008 A1
20080112534 DeFreitas et al. May 2008 A1
20080130979 Ren Jun 2008 A1
20080177127 Allan et al. Jul 2008 A1
20080188705 Lubock et al. Aug 2008 A1
20080221384 Chi Sing et al. Sep 2008 A1
20080221444 Ritchie et al. Sep 2008 A1
20080228023 Jones et al. Sep 2008 A1
20080228024 Jones et al. Sep 2008 A1
20080228025 Quick Sep 2008 A1
20080228150 Jones et al. Sep 2008 A1
20080281142 Lubock et al. Nov 2008 A1
20080281143 Lubock et al. Nov 2008 A1
20080287801 Magnin et al. Nov 2008 A1
20090003519 Defreitas Jan 2009 A1
20090010384 Jing Jan 2009 A1
20090030259 Quick Jan 2009 A1
20090080594 Brooks Mar 2009 A1
20090080602 Brooks Mar 2009 A1
20090093821 Edmundson Apr 2009 A1
20090124845 Lubock et al. May 2009 A1
20090135997 Defreitas May 2009 A1
20090156880 Allan et al. Jun 2009 A1
20090156882 Chi Sing et al. Jun 2009 A1
20090171157 Diedrich et al. Jul 2009 A1
20090188098 Acosta et al. Jul 2009 A1
20090198095 Acosta et al. Aug 2009 A1
20090213987 Stein et al. Aug 2009 A1
20090268865 Ren Oct 2009 A1
20090296882 Gkanatsios Dec 2009 A1
20090304147 Jing et al. Dec 2009 A1
20100048977 Sing et al. Feb 2010 A1
20100054400 Ren Mar 2010 A1
20100069878 Parsai et al. Mar 2010 A1
20100086188 Ruth Apr 2010 A1
20100150306 Defreitas et al. Jun 2010 A1
20100195882 Ren Aug 2010 A1
20100204534 Damarati Aug 2010 A1
20100204535 Damarati Aug 2010 A1
20100226475 Smith Sep 2010 A1
20100268029 Phan Oct 2010 A1
20100286465 Benson Nov 2010 A1
20100290585 Eliasson Nov 2010 A1
20110069809 Defreitas et al. Mar 2011 A1
20120046647 Matsukuma et al. Feb 2012 A1
20120071705 Lubock et al. Mar 2012 A1
20120088952 Lubock et al. Apr 2012 A1
20120178983 Benson Jul 2012 A1
20130225902 White Aug 2013 A1
20170080252 Lubock et al. Mar 2017 A1
Foreign Referenced Citations (55)
Number Date Country
2539553 Mar 1977 DE
0340881 Oct 1992 EP
0536440 Apr 1993 EP
0642766 Mar 1995 EP
0693293 Jan 1996 EP
0719571 Jul 1996 EP
775467 May 1997 EP
0853957 Jul 1998 EP
0867200 Sep 1998 EP
0982001 Mar 2000 EP
1051990 Nov 2000 EP
1070514 Jan 2001 EP
1402922 Mar 2004 EP
1428473 Jun 2004 EP
1541188 Jun 2005 EP
1618924 Jan 2006 EP
1759637 Mar 2007 EP
10137250 May 1998 JP
2001120561 May 2001 JP
2177350 Dec 2001 RU
WO 9005485 May 1990 WO
WO 9210932 Jul 1992 WO
WO 9309724 May 1993 WO
WO 9520241 Jul 1995 WO
WO 9712540 Apr 1997 WO
WO 9719723 Jun 1997 WO
WO 9745053 Dec 1997 WO
WO 9816903 Apr 1998 WO
WO 9815315 Apr 1998 WO
WO 9911325 Mar 1999 WO
WO 9933515 Jul 1999 WO
WO 9934869 Jul 1999 WO
WO 9942163 Aug 1999 WO
WO 0051484 Sep 2000 WO
WO 0114011 Mar 2001 WO
WO 0143826 Jun 2001 WO
WO 0158346 Aug 2001 WO
WO 0209599 Feb 2002 WO
WO 02069862 Sep 2002 WO
WO 03020114 Mar 2003 WO
WO 2004043531 May 2004 WO
WO 2004043535 May 2004 WO
WO 2005037363 Apr 2005 WO
WO 2005039655 May 2005 WO
WO 2005039665 May 2005 WO
WO 2005051197 Jun 2005 WO
WO 2005067442 Jul 2005 WO
WO 2005110230 Nov 2005 WO
WO 2005112767 Dec 2005 WO
WO 2006055830 May 2006 WO
WO 2006058160 Jun 2006 WO
WO 2007027831 Mar 2007 WO
WO 2007143560 Dec 2007 WO
WO 2008067557 Jun 2008 WO
WO 09079170 Jun 2009 WO
Non-Patent Literature Citations (75)
Entry
“DuPont Teflon PFA HP Plus”, XP007904995:retrieved from the internet: URL: http://www2.dupont.com/Teflon_Industrial/en_US/assets/downloads/ h88800.pdf; retrieved on Jun. 19, 2008, by Authorized Officer in International Application PCT/US2008/003364, 4 pgs.
“Essentials for life: Senographe Essential Full-Field Digital Mammography system”, GE Health-care Brochure, MM-0132-05.06-EN-US, 2006, 12 pgs.
“Filtered Back Projection,” (NYGREN) published May 8, 2007; URL:http://web.archive.org/web/19991010131715/http://www.owlnet.rice.edu/-.about.e1ec539/Projects97/cult/node2.html, 2 pgs.
“Lorad Selenia” Document B-BI-SEO US/Intl (May 2006), copyright Hologic 2006, 12 pgs.
“Variable shield for radiation-therapy sourcewire and centering catheter”, Research disclosure, Mason Publications, Hampshire, GB, vol. 438, No. 48, Oct. 2000, XP007126916, 1 page.
Abstracts of the 11th International Conference on Brain tumor Research and Therapy Oct. 31-Nov. 3, 1995, Silverado Country Club and Resort, Napa, California, Journal of Neuro-Oncology 28, p. 72, 1996, 2 pages all together.
Akagi, Y, et al.,“Optimum Fractionation for High-Dose-Rate Endoesophageal Brachytherapy Following External Irradiation of Early State Esophageal Cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 43, 1999, pp. 525-530, Elsevier Science, Inc.
Ashpole et al., “A New Technique of Brachytherapy for Malignant Gliomas with Caesium-137: A New Method Utilizing a Remote Afterloading System,” Clinical Oncology, 1990, vol. 2, pp. 333-337.
Astrahan, Melvin A., PhD et al., “Optimization of Mammosite therapy”, Int. J. Radiation Oncology Biol. Phys, vol. 58, No. 1, pp. 220-232, 2004.
Bowsher. W. G., et al., “Update on Urology-Prostate Cancer. 4-Treatment of Local Disease”. European Journal of Surgical Oncology. 1995 pp. 679-682. vol. 21. No. 6.
Chan, Heang-Ping et al., “ROC study of the effect of stereoscopic imaging on assessment of breast lesions”, Medica Physics, vol. 32, No. 4, Apr. 2005, 7 pgs.
Cole, Elodia, et al., “The Effects of Gray Scale Image Processing on Digital Mammography Interpretation Performance”, Academic Radiology, vol. 12, No. 5, pp. 585-595, May 2005.
Cuttino, L. W., et al.,“CT-Guided Multi-Catheter Insertion Technique for Partial Breast Brachytherapy: Reliable Target Coverage and Dose Homogeneity”, Brachy1herapy 4, 2005, pp. 10-17, Elsevier.
Das, R. K., et al., “3D-CT-Based High-Dose-Rate Breast Brachytherapy Implants: Treatment Planning and Quality Assurance”, Int. J. Radiation Oncology Biol. Phys. 2004, pp. 1224-1228, vol. 59, No. 4, Elsevier Inc.
Debicki, M. P., et al., “Localized Current Field Hyperthermia in Carcinoma of the Cervix: 3-D Computer Simulation of SAR Distribution”. International Journal of Hyperthermia. 1999. pp. 427-440. vol. 15. No. 5.
Demanes, D. J . et al., “The Use and Advantages of a Multichannel Vaginal Cylinder in High-Dose-Rate Brachytherapy”. Int. J. Radiation Oncology Biol. Phys. (1999). pp. 211-219. vol. 44. No. 1. Elsevier Science Inc.
Dempsey, J. F. et al., “Dosimetric Properties of a Novel Brachytherapy Balloon Applicator for the Treatment of Malignant Brain-Tumor Resection-Cavity Margins”, Int. J. Radiation Oncology Biol. Phys., May 1998, pp. 421-429, vol. 42. No. 2. Elsevier.
Devic et al., “Advantages of Inflatable Multichannel Endorectal Applicator in the Neo-Adjuvant Treatment of Patients With Locally Advanced Rectal Cancer With HOR Brachytherapy”, Journal of Applied Clinical Medical Physics, Spring 2005, pp. 44-49, vol. 6, No. 2.
Digital Clinical Reports, Tomosynthesis, GE Brochure 98/5493, Nov. 1998, 8 pgs.
Edmundson,Gregory K. et al., “Dosimetric Characteristics of the Mammosite RTS, a New Breast Brachytherapy Applicator”, Int. J. Radiation Oncology Biol. Phys., vol. 52, No. 4, pp. 1132-1139, 2002.
Federica Pediconi et al., “Color-coded automated signal intensity-curve for detection and characterization of breast lesions: Preliminary evaluation of a new software for MR-based breast imaging”, International Congress Series 1281 (2005) 1081-1086.
Fowler, J. E., “Brief Summary of Radiobiological Principles in Fractionated Radiotherapy”, Seminars in Radiation Oncology, Jan. 1992, pp. 16-21, vol. 2, No. 1, W. B. Saunders Company.
Friedman, M, et al., “A New Technic for the Radium Treatment of Carcinoma of the Bladder”, Presented at the Thirty-fourth Annual Meeting of the Radiological Society of North America, Dec. 5-10, 1948, pp. 342-362.
Friedman, M, et al., “Irradiation of Carcinoma of the Bladder by a Central Intracavitary Radium or Cobalt 60 Source (The Walter Reed Technique)”, Presented at the Annual Meeting of the American Radium Society, 1955, pp. 6-31.
Garipagaoglu, M. et al., “Geometric and Dosimetric Variations of ICRU Bladder and Rectum Reference Points in Vaginal Cuff Brachytherapy Using Ovoids”, Int. J. Radiation Oncology Biol. Phys. 2004, pp. 1607-1615. Elsevier Inc.
Gaspar, L. E., et al., “Esophageal Brachytherapy”, Principles and Practice of Brachytherapy, 1997, pp. 305-321, Futrua Publishing Company, Inc., Armouk, New York.
Glasgow, G. P., et al. “Remote Afterloading Technology”, AAPM Report No. 41, 1993, pp. i-vi and 1-107, American Institute of Physics, Inc., 116 pgs.
Gutin, P.H. et al., “A coaxial catheter system for afterloading radioactive sources for the interstitial irradiation of brain tumors”, J. Neurosur, vol. 56, pp. 734-735, 1982.
Hall, J. W., et al., “Histologic Changes in Squamous-Cell Carcinoma of the Mouth and Oropharynx Produced by Fractionated External Roentgen Irradiation”, Radiological Society of North America, 1948, pp. 318-350, Mar. 3, 1950.
Harada, T, et al.,“Transcystoscopic Intracavitary irradiation for Carcinoma of the Bladder: Technique and Preliminary Clinical Results”, The Journal of Urology, Oct. 1987, pp. 771-774, vol. 138, No. 4, The Williams & Wilkins Co.
Harper, Paul V., “Some Therapeutic Applications of Radioisotopes”, Journal of the Mississippi State Medical Association, Oct. 1966, vol. VII, pp. 526-533.
Hewitt, C. B., et al., “Intracavitary Radiation in the Treatment of Bladder Tumors”, The Journal of Urology, vol. 107, Apr. 1972, pp. 603-606, The Williams & Wilkins Co.
Hewitt, C. B., et al., “Update on Intracavitary Radiation in the Treatment of Bladder Tumors”, The Journal of Urology; Official Journal of the American Urological Association, Inc., 1981, pp. 323-325, vol. 126 September, The Williams & Wilkins Co.
Hieshima,G. B., et al. “A Detachable Balloon for Therapeutic Transcatheter Occlusions 1”, Technical Notes, Jan. 1981, pp. 227-228, vol. 138.
Hine, G. J., et al., “Isodose Measurements of Linear Radium Sources in Air and Water by Means of an Automatic Isodose Recorder”, The American Journal of Roentgenology and Radium Therapy, 1950, pp. 989-998, vol. 64, No. 6, The Societies.
Hoshino, T., “Brain Tumor Research Center”, Abstracts of the 11th Conference on Brain Tumor Research and Therapy, Journal of Neuro-Oncology 28, 1996, pp. 31-113.
Johannesen, T.B. et al, “Intracavity Fractioned Balloon Brachytherapy in Glioblastoma”, Acta Neurochir (Wien) (1999) 141: 127-133.
Kaufman, N., “Remote Afterloading Intraluminal Brachytherapy in the Treatment of Rectal, Rectosigmoid, and Anal Cancer: A Feasibility Study”, International Journal of Radiation Oncology, Biology, Physics, Sep. 1989, pp. 663-668, vol. 17, Issue 3, Pergamon Press pic.
Kita et al., “Correspondence between different view breast X-rays using simulation of breast deformation”, Proceedings 1998 IEE Computer Society Conference on Computer Vision and Pattern Recognition, Santa Barbara, CA, Jun. 23-25, 1998, pp. 700-707.
Kolotas., C. et al., “CT Guided Interstitial High Dose Rate Brachytherapy for Recurrent Malignant Gliomas”. The British Journal of Radiology. 72. (1999), pp. 805-808.
Kuettel, M. R. et al.. “Treatment of Female Urethral Carcinoma in Medically Inoperable Patients Using External Beam Irradiation and High Dose Rate Intracavitary Brachytherapy”, The Journal of Urology. May 1997, pp. 1669-1671, vol. 157, The American Urological Association, Inc.
Lewis, J, et al., “Intracranial Brachytherapy Using a High Dose Rate Microselectron”, Northern Centre for Cancer Treatment, Dept. of Neurosciences, Regional Medical Physics Department, Newcastle General Hospital, Newcastle Upon Tyne, UK, Radiation and Oncology, vol. 39, Supplement 1, May 1996, pp. 45-45, 1 page, p. 179.
Low-Beer, B. V. A., “Radioisotope Therapy”, “The Clinical Use of Radioactive Isotopes”, 1950, pp. 284-349, Charles C. Thomas, Publisher, Springfield, Illinois, U.S.A., See pp. 343-349.
Low-Beer, B. V. A., “The Therapeutic Use of Radioactive Isotopes”, “Practical Therapeutics”, Dec. 1954, pp. 69-87, vol. X, No. 6.
Mammographic Accreditation Phantom, http://www.cirsinc.com/pdfs/015cp.pdf, (2006), 2 pgs.
Marshall V. F., et al., “Current Clinical Problems Regarding Bladder Tumors”, Symposium on Bladder Tumors, 1956, pp. 543-550, 9/3/May-Jun, J.B. Lippincott Co, Etc.
Micheletti, E., et al., “High-Dose-Rate Brachytherapy for Poor-Prognosis, High-Grade Glioma: (Phase II) Preliminary Results”, Tumori, 1996, pp. 339-344.
Muller, J. H., “Radiotherapy of Bladder Cancer by Means of Rubber Balloons Filled In Situ With solutions of a Radioactive Isotope (Co60)”, Cancer, A Journal of the American Cancer Society, Jul.-Aug. 1955, pp. 1035-1043, vol. 8, No. 4, J.B. Lippincott Company, Philadelphia.
Nag, S, “Modern Techniques of Radiation Therapy for Endometrial Cancer”, Clinical Obstetrics and Gynecology, Sep. 1996, pp. 728-744, vol. 39, No. 3, Lippincott-Raven Publishers.
Nag, S., et al., “Perineal Template Interstitial Barchytherapy Salvage for Recurrent Endometrial Adenocarcinoma Metastatic to the Vagina”, Necologic Oncology 66, 1997, pp. 16-19, Article No. G0974722, Academic Press.
Nag, S., et al., “Remote Controlled High Dose Rate Brachytherapy”, Critical Reviews in Oncology/Hematology 22, 1996, pp. 127-150, Elsevier Science Ireland Ltd.
Nag, S., et al., “The Future of High Dose Rate Brachytherapy”, High Dose Rate Brachytherapy: A Textbook, 1994, pp. 447-453, Futura Publishing Company, Inc. , Armonk, New York 10504.
Nath, Ph.D. et al., “Development of an 241 Am Applicator for Intracavitary Irradiation of Gynecologic Cancers”, I.J. Radiation Oncology Biol. Phys., May 1988, vol. 14, p. 969-978.
Pernot, M., “Combined Surgery and Brachytherapy in the Treatment of Some Cancers of the Bladder (Partial Cystectomy and Interstitial Iridium—192)”, Radiotherapy & Oncology, 1996, pp. 115-120, Elsevier Science Ireland Ltd.
Rotman, M., et al., “The Intracavitary Applicator in Relation to Complications of Pelvic Radiation—The Ernst System”, Int. J. Radiation Oncology Biol. Phys., 1978, pp. 951-956, vol. 4, Pergamon Press Inc.
Russel, A.H., et al, “Intracavitary Irradiation for Carcinoma of the Urinary Bladder: Rationale, Technique, and Preliminary Results”, Int. J. Radiation Oncology. Phys., 1984, pp. 215-219, vol. 10, Pergamon Press Ltd.
Senographe 700 & 800T (GE); 2-page download on Jun. 22, 2006 from www.gehealthcare.com/inen/rad/whe/products/mswh800t.html.; Figures 1-7 on 4 sheets re lateral shift compression paddle, 2 pgs.
Slevin. N. J. et al., “Intracavitary Radiotherapy Boosting for Nasopharynx Cancer”, The British Journal of Radiology, 70, Apr. 1997, pp. 412-414.
Smith, A., “Fundamentals of Breast Tomosynthesis”, White Paper, Hologic Inc., WP-00007, Jun. 2008, 8 pgs.
Sneed. P. K. et al., “Interstitial Brachytherapy Procedures for Brain Tumors”, Seminars in Surgical Oncology 1997; 13: 157-166. Wiley-Liss. Inc.
Stubbs, J.B., et al.,“Preclinical Evaluation of a Novel Device for Delivering Brachytherapy to the Margins of Resected Brain Tumor Cavities”, J. Neurosurg 96, Feb. 2002, pp. 335-343, vol. 96.
Sylvester, J., et al., “Interstitial Implantation Techniques in Prostate Cancer”, Journal of Surgical Oncology 1997; 66: 65-75. Wiley-Liss. Inc.
Symon et al., “Individual Fraction Optimization vs. First Fraction Optimization for Multichannel Applicator Vaginal Cuff High-Dose-Rate Brachytherapy”, pp. 211-215, Brachytherapy 5 (2006), Elsevier.
Tan, L. T. et al., “Radical Radiotherapy for Carcinoma of the Uterine Cervix Using External Beam Radiotherapy and a Single Line Source Brachytherapy Technique: The Clatterbridge Technique”, The British Journal of Radiology, 70, Dec. 1997, pp. 1252-1258.
Tanderup et al. “Multi-Channel Intracavitary Vaginal Brachytherapy Using Three-Dimensional Optimization of Source Geometry”, Radiation & Oncology Journal of the European Society for Therapeutic Radiology and Oncology, 2004, pp. 81-85, Radiotherapy and Oncology 70 (2004), Elsevier Ireland Ltd.
Vicini, F. A., et al, “Dose-Volume Analysis for Quality Assurance of Interstitial Brachytherapy for Breast Cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 45, 1999, pp. 803-810, Elsevier Science Inc.
Voung, T, et al., “High-Dose-Rate Endorectal Brachytherapy in the Treatment of Loacally Advanced Rectal Carcinoma: Technical Aspects”, Brachytherapy 4, 2005, pp. 230-235, Elsevier.
Walton, R. J., “Therapeutic Uses of Radioactive Isotopes in the Royal Cancer Hospital”, The British Journal of Radiology, 1950, pp. 559-599, William Heinemann, Publisher.
Walton, R. J., et al., Radioactive Solution (24Na and 82 Br) in the Treatment of Carcinoma of the Bladder:, British Medical Bulletin, 1952, pp. 158-165, Medical Dept., The British Council.
Wang, C. C., “Carcinoma of the Nasopharynx”, Radiation Therapy of Head and Neck Neoplasms, 1997, pp. 257-280, Chapter 10, Wiley-Liss, Inc.
Wheeler, F.W. et al. (2006), “Micro-Calcification Detection in Digital Tomosynthesis Mammography”, Proceedings of SPIE, Conf-Physics of Semiconductor Devices, Dec. 11, 2001 to Dec. 15, 2001, Delhi, SPIE, US, vol. 6144, Feb. 13, 2006, 12 pgs.
Wolf, C. D., et al., “A Unique Nasopharynx Brachytherapy Technique”, Official Journal of the American Association of Medical Dosimetrists, 1990, pp. 133-136, vol. 15, Issue No. 3., Pergamon Press.
Wu, Tao et al., “Tomographic mammography using a limited number of low-dose cone-beam images”, Medical Physics, AIP, Melville, NY, vol. 30, No. 3, Mar. 1, 2003, pp. 365-380.
Xu, Z., et al., “Calculation of Dose Distribution Near an Innovative Concentric Balloon Catheter for Endovascular Brachytherapy”, Cardiovascular Radiation Medicine 2, 2000, pp. 26-31, Elsevier Science Inc.
Yin, W., “Brachytherapy of Carcinoma of the Esophagus in China, 1970-1974 and 1982-1984”, Brachytherapy HOR and LOR, May 4-6, 1989, pp. 52-56.
Related Publications (1)
Number Date Country
20160287902 A1 Oct 2016 US
Continuations (1)
Number Date Country
Parent 12894888 Sep 2010 US
Child 15167589 US